New program aims to close colorectal cancer screening gap for Low-Income and minority communities

NCT ID NCT06090643

Ongoing Prevention Sponsor: Jonsson Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a culturally tailored program to increase colorectal cancer screening among low-income and ethnic minority groups, who are disproportionately affected by the disease. Nearly 10,000 patients aged 50-75 will receive education, consultations, and fecal immunochemical test (FIT) kits. The goal is to improve screening rates and catch cancer earlier, when it's easier to treat.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fecal immunochemical test (FIT) screening program
What this could lead to: If successful, this program could significantly increase colorectal cancer screening rates in underserved communities, helping detect cancer earlier and reduce health disparities.
What could go wrong: This is an implementation study, not a test of a new treatment. Success depends on real-world uptake, and results may not apply to other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal carcinoma colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CARCINOMA

Contacts and locations

Locations

UCLA / Jonsson Comprehensive Cancer Center

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.